Metformin causes gastrointestinal side effects in roughly 20% of people who take it. Diarrhea, nausea, bloating, and stomach pain are by far the most common complaints, and they tend to be worst during the first few weeks of treatment. Most people find these effects manageable and temporary, but a smaller number experience issues that persist or, in rare cases, require switching to a different medication.
Common Gastrointestinal Side Effects
The gut-related side effects are so well documented that they’re almost expected when starting metformin. The full list includes nausea, diarrhea, abdominal bloating, flatulence, vomiting, constipation, heartburn, stomach cramps, and loss of appetite. In clinical trials, about 28% of people on metformin reported gastrointestinal symptoms compared with 16% on placebo, which means roughly half the stomach trouble people experience on the drug would have happened anyway.
These effects happen because metformin is highly active in the gut. It alters the composition of intestinal bacteria, increases the production of lactic acid locally in the intestines, and raises levels of certain hormones and bile acids that influence digestion. The exact mechanism still isn’t fully understood, but the result is a digestive system that needs time to adjust.
A metallic or altered taste is another frequently reported side effect that catches people off guard. It’s harmless but can be persistent enough to affect appetite. Other non-gut symptoms include headache, dizziness, fatigue, muscle aches, and occasionally upper respiratory symptoms like a runny nose or sore throat.
How to Reduce Side Effects
The single most effective strategy is starting at a low dose and increasing slowly. The standard approach is to begin with 500 mg once or twice daily, taken with meals, then increase gradually over several weeks. This gives your gut time to adapt. If symptoms flare up at a higher dose, a temporary step back often helps before trying to increase again.
Taking metformin with food makes a noticeable difference. The tablets should be split into divided doses throughout the day rather than taken all at once, and eating a full meal before each dose buffers the impact on your stomach.
If side effects persist despite slow titration and taking the medication with food, switching to the extended-release formulation is the next step. Extended-release metformin dissolves more slowly in the gut, and studies consistently show it produces fewer gastrointestinal side effects than the standard immediate-release version. Many people who couldn’t tolerate the original form do well on extended-release.
Vitamin B12 Deficiency Over Time
This is the side effect that gets the least attention but affects a significant number of long-term users. Up to 10% of people taking metformin develop vitamin B12 deficiency because the drug interferes with B12 absorption in the intestines. The risk increases the longer you take it and the higher your dose.
B12 deficiency develops slowly, often over years, and the symptoms can be subtle at first: fatigue, weakness, tingling or numbness in the hands and feet, difficulty concentrating, and mood changes. Because these overlap with symptoms of diabetes itself, they’re easy to miss. Left untreated, B12 deficiency can cause lasting nerve damage.
The UK’s medicines regulator recommends checking B12 levels as part of annual blood work for people on long-term metformin, especially those with other risk factors for deficiency (such as older age or a vegetarian diet). In practice, routine screening is uncommon. Fewer than 20% of eligible patients get their B12 tested annually. If you’ve been on metformin for more than a year or two and haven’t had your B12 checked, it’s worth asking about.
Weight Changes
Unlike many diabetes medications, metformin doesn’t cause weight gain. Most people experience modest weight loss. In a large clinical trial, people on metformin lost an average of 2.1 kg (about 4.5 pounds) over roughly three years, compared to almost no change in the placebo group. Over longer follow-up, around 30% of participants lost more than 5% of their body weight in the first year, and some maintained a 6.2% loss after 15 years.
The weight loss is real but moderate. Across studies, the typical range is 2 to 3 kg, though some trials have reported averages closer to 5 to 6 kg in specific populations. People taking antipsychotic medications, which often cause significant weight gain, lost an average of 3.3 kg on metformin compared to controls. For most people, the weight effect is a welcome side benefit rather than a dramatic change.
Lactic Acidosis: Rare but Serious
Lactic acidosis is the side effect that generates the most concern, and it’s genuinely dangerous when it occurs. It happens when lactic acid builds up in the blood faster than the body can clear it. The reported rate is about 0.06 per 1,000 patient-years, which means it’s extremely uncommon, and it occurs almost exclusively in people who have additional risk factors like severe kidney disease, liver problems, heart failure, or heavy alcohol use.
The warning signs are vague, which is part of what makes it dangerous: nausea, vomiting, stomach pain, unusual fatigue, loss of appetite, rapid or difficult breathing, feeling cold, and an altered level of consciousness. These symptoms overlap with many other conditions, but the combination of several at once, especially rapid breathing and confusion, warrants immediate medical attention.
Alcohol increases the risk because it impairs the same metabolic pathways that clear lactic acid from the blood. Occasional moderate drinking is generally considered acceptable, but heavy or binge drinking while on metformin meaningfully raises the danger.
Kidney Function and Dose Limits
Your kidneys are responsible for clearing metformin from your body. When kidney function declines, metformin accumulates, which raises the risk of lactic acidosis. Current guidelines tie the maximum safe dose directly to how well your kidneys are filtering:
- Normal kidney function (eGFR 60-120): up to 2,000 mg daily
- Mild to moderate impairment (eGFR 30-60): up to 1,000 mg daily
- Significant impairment (eGFR 15-30): up to 500 mg daily
- Severe impairment (eGFR below 15): metformin is not recommended
These thresholds have been relaxed considerably over the years. Metformin used to be off-limits for anyone with even moderate kidney issues, but evidence showed that cautious dosing at lower kidney function levels is safe. Routine blood work to monitor kidney function is standard for anyone on the medication long-term, and your dose may be adjusted downward if your numbers shift.